Swati Kulkarni

In this engaging discussion, Dr. Swati Kulkarni, a leading surgical researcher at Northwestern University, uncovers new insights on hormone therapy for women with ductal carcinoma in situ (DCIS). She explains what DCIS is and its risks, including potential progression to invasive cancer. The conversation delves into a groundbreaking study using conjugated estrogens and bazodoxifene, showing promising results in reducing cancer cell development. Also explored are the challenges of recruiting participants and the impact of hormone therapy on quality of life, providing hopeful avenues for breast cancer management.